| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premenstrual Syndrome | 30 | 2026 | 99 | 9.400 |
Why?
|
| Menopause | 22 | 2024 | 257 | 6.100 |
Why?
|
| Diet | 22 | 2024 | 540 | 3.730 |
Why?
|
| Menopause, Premature | 9 | 2023 | 25 | 3.690 |
Why?
|
| Vitamin D | 16 | 2022 | 139 | 3.680 |
Why?
|
| Anti-Mullerian Hormone | 12 | 2024 | 68 | 3.580 |
Why?
|
| Prospective Studies | 62 | 2025 | 3340 | 3.180 |
Why?
|
| Risk Factors | 70 | 2026 | 5477 | 2.590 |
Why?
|
| Female | 153 | 2026 | 34459 | 2.560 |
Why?
|
| Postmenopause | 17 | 2022 | 241 | 2.550 |
Why?
|
| Adult | 104 | 2026 | 17595 | 2.410 |
Why?
|
| Depression | 15 | 2026 | 910 | 2.120 |
Why?
|
| Bone Density | 5 | 2026 | 142 | 1.960 |
Why?
|
| Premenopause | 11 | 2024 | 60 | 1.950 |
Why?
|
| Humans | 160 | 2026 | 65872 | 1.850 |
Why?
|
| Young Adult | 46 | 2026 | 4887 | 1.830 |
Why?
|
| Breast Feeding | 3 | 2024 | 166 | 1.770 |
Why?
|
| Body Mass Index | 22 | 2024 | 903 | 1.720 |
Why?
|
| Hot Flashes | 3 | 2024 | 102 | 1.680 |
Why?
|
| Dietary Proteins | 3 | 2019 | 44 | 1.640 |
Why?
|
| Case-Control Studies | 25 | 2026 | 1150 | 1.630 |
Why?
|
| Menarche | 3 | 2024 | 37 | 1.610 |
Why?
|
| Self Report | 10 | 2024 | 395 | 1.540 |
Why?
|
| Nurses | 11 | 2024 | 114 | 1.510 |
Why?
|
| Exercise | 9 | 2026 | 970 | 1.500 |
Why?
|
| Adolescent | 38 | 2026 | 6371 | 1.380 |
Why?
|
| Sterilization, Tubal | 2 | 2021 | 11 | 1.380 |
Why?
|
| Stress, Psychological | 9 | 2026 | 475 | 1.370 |
Why?
|
| Menstrual Cycle | 9 | 2025 | 83 | 1.360 |
Why?
|
| Middle Aged | 63 | 2026 | 18518 | 1.350 |
Why?
|
| Dietary Fats | 5 | 2023 | 178 | 1.300 |
Why?
|
| Parity | 3 | 2021 | 71 | 1.290 |
Why?
|
| Surveys and Questionnaires | 29 | 2024 | 2790 | 1.280 |
Why?
|
| Sexual and Gender Minorities | 4 | 2024 | 76 | 1.280 |
Why?
|
| Inflammation | 9 | 2023 | 1196 | 1.260 |
Why?
|
| Calcium, Dietary | 4 | 2017 | 28 | 1.250 |
Why?
|
| Premenstrual Dysphoric Disorder | 4 | 2026 | 9 | 1.220 |
Why?
|
| Breast | 4 | 2022 | 194 | 1.210 |
Why?
|
| Feeding Behavior | 5 | 2024 | 266 | 1.190 |
Why?
|
| Breast Neoplasms | 12 | 2022 | 1235 | 1.180 |
Why?
|
| Age Factors | 12 | 2025 | 1595 | 1.140 |
Why?
|
| Proportional Hazards Models | 14 | 2026 | 746 | 1.130 |
Why?
|
| Cohort Studies | 21 | 2026 | 2653 | 1.120 |
Why?
|
| Cholecalciferol | 4 | 2022 | 28 | 1.100 |
Why?
|
| Cross-Sectional Studies | 28 | 2025 | 2742 | 1.080 |
Why?
|
| Women's Health | 6 | 2022 | 376 | 1.070 |
Why?
|
| Health Surveys | 4 | 2024 | 319 | 1.060 |
Why?
|
| Nutritional Status | 2 | 2018 | 101 | 1.050 |
Why?
|
| Cardiovascular Diseases | 5 | 2025 | 878 | 1.030 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2018 | 86 | 1.030 |
Why?
|
| Premature Birth | 6 | 2025 | 116 | 1.020 |
Why?
|
| Odds Ratio | 14 | 2026 | 757 | 1.020 |
Why?
|
| Diet, Vegetarian | 2 | 2026 | 5 | 1.000 |
Why?
|
| Suicide | 4 | 2026 | 148 | 0.960 |
Why?
|
| Emotions | 4 | 2021 | 236 | 0.950 |
Why?
|
| Calcium | 4 | 2017 | 587 | 0.940 |
Why?
|
| Fatty Acids | 3 | 2023 | 200 | 0.880 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 180 | 0.870 |
Why?
|
| Heterosexuality | 1 | 2024 | 10 | 0.870 |
Why?
|
| Interleukin-10 | 3 | 2023 | 163 | 0.870 |
Why?
|
| Logistic Models | 14 | 2026 | 1274 | 0.860 |
Why?
|
| Pregnancy | 21 | 2026 | 2411 | 0.860 |
Why?
|
| Bone and Bones | 1 | 2026 | 152 | 0.860 |
Why?
|
| Contraceptives, Oral | 2 | 2021 | 23 | 0.860 |
Why?
|
| Adiposity | 3 | 2022 | 89 | 0.850 |
Why?
|
| Alcohol Drinking | 3 | 2021 | 325 | 0.850 |
Why?
|
| C-Reactive Protein | 8 | 2023 | 171 | 0.850 |
Why?
|
| Cigarette Smoking | 3 | 2021 | 56 | 0.840 |
Why?
|
| Dietary Supplements | 9 | 2022 | 236 | 0.830 |
Why?
|
| Vitamins | 5 | 2022 | 80 | 0.830 |
Why?
|
| Dairy Products | 4 | 2019 | 16 | 0.810 |
Why?
|
| Diabetes, Gestational | 3 | 2022 | 142 | 0.770 |
Why?
|
| Prevalence | 9 | 2026 | 1455 | 0.740 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2019 | 29 | 0.740 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 155 | 0.730 |
Why?
|
| Rural Population | 3 | 2016 | 225 | 0.720 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 51 | 0.700 |
Why?
|
| Alcoholic Beverages | 1 | 2021 | 7 | 0.700 |
Why?
|
| Chronic Pain | 1 | 2024 | 154 | 0.700 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 72 | 0.690 |
Why?
|
| Mental Health | 4 | 2023 | 368 | 0.680 |
Why?
|
| Incidence | 12 | 2026 | 1434 | 0.680 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 14 | 0.670 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1299 | 0.670 |
Why?
|
| Refugees | 4 | 2026 | 75 | 0.660 |
Why?
|
| Suicidal Ideation | 3 | 2026 | 133 | 0.650 |
Why?
|
| Environmental Exposure | 5 | 2022 | 228 | 0.650 |
Why?
|
| Eating | 2 | 2019 | 140 | 0.640 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 2500 | 0.630 |
Why?
|
| HIV Infections | 7 | 2023 | 961 | 0.620 |
Why?
|
| Recreation | 3 | 2017 | 20 | 0.600 |
Why?
|
| Endometriosis | 4 | 2024 | 27 | 0.600 |
Why?
|
| Smoking | 7 | 2019 | 864 | 0.600 |
Why?
|
| Pregnancy Outcome | 5 | 2025 | 202 | 0.590 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2019 | 4 | 0.590 |
Why?
|
| Smoking Cessation | 4 | 2023 | 553 | 0.590 |
Why?
|
| Thinness | 2 | 2017 | 44 | 0.590 |
Why?
|
| United States | 20 | 2024 | 8192 | 0.580 |
Why?
|
| Zinc | 3 | 2016 | 95 | 0.580 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 71 | 0.580 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 104 | 0.570 |
Why?
|
| Dietary Fiber | 2 | 2018 | 80 | 0.570 |
Why?
|
| Coffee | 2 | 2016 | 18 | 0.570 |
Why?
|
| Absorptiometry, Photon | 3 | 2026 | 76 | 0.570 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 8 | 0.560 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 932 | 0.560 |
Why?
|
| Caffeine | 2 | 2016 | 46 | 0.560 |
Why?
|
| Dogs | 2 | 2012 | 327 | 0.560 |
Why?
|
| Dietary Carbohydrates | 2 | 2018 | 62 | 0.550 |
Why?
|
| Ovarian Neoplasms | 4 | 2006 | 170 | 0.550 |
Why?
|
| Massachusetts | 17 | 2026 | 2161 | 0.540 |
Why?
|
| Triglycerides | 1 | 2019 | 252 | 0.520 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2018 | 13 | 0.520 |
Why?
|
| Lymphoma | 2 | 2012 | 101 | 0.510 |
Why?
|
| Antidepressive Agents | 4 | 2022 | 244 | 0.500 |
Why?
|
| Biomarkers | 10 | 2023 | 1506 | 0.490 |
Why?
|
| Coffea | 1 | 2016 | 1 | 0.490 |
Why?
|
| Risk Assessment | 7 | 2025 | 2116 | 0.480 |
Why?
|
| Sweden | 9 | 2026 | 65 | 0.480 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2007 | 55 | 0.480 |
Why?
|
| Anxiety | 4 | 2026 | 427 | 0.480 |
Why?
|
| Life Style | 4 | 2026 | 324 | 0.470 |
Why?
|
| Child | 8 | 2024 | 4656 | 0.470 |
Why?
|
| Atherosclerosis | 1 | 2018 | 162 | 0.470 |
Why?
|
| Body Composition | 2 | 2021 | 155 | 0.470 |
Why?
|
| Hypertension | 3 | 2016 | 618 | 0.460 |
Why?
|
| Marijuana Smoking | 2 | 2026 | 20 | 0.460 |
Why?
|
| Marijuana Use | 2 | 2026 | 23 | 0.460 |
Why?
|
| Finland | 4 | 2022 | 21 | 0.460 |
Why?
|
| Aged | 19 | 2026 | 15155 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2026 | 735 | 0.450 |
Why?
|
| Seasons | 1 | 2016 | 140 | 0.450 |
Why?
|
| Infertility, Female | 3 | 2024 | 47 | 0.440 |
Why?
|
| Estrogens | 4 | 2010 | 115 | 0.440 |
Why?
|
| Vitamin B Complex | 2 | 2014 | 15 | 0.440 |
Why?
|
| Linear Models | 8 | 2024 | 405 | 0.430 |
Why?
|
| Schools | 2 | 2026 | 170 | 0.430 |
Why?
|
| Mental Disorders | 4 | 2026 | 827 | 0.430 |
Why?
|
| Androgens | 4 | 2023 | 67 | 0.420 |
Why?
|
| Osteoporosis | 2 | 2013 | 113 | 0.420 |
Why?
|
| Domestic Violence | 1 | 2014 | 40 | 0.420 |
Why?
|
| Abortion, Spontaneous | 2 | 2025 | 30 | 0.410 |
Why?
|
| Estradiol | 5 | 2022 | 260 | 0.410 |
Why?
|
| Sex Offenses | 1 | 2014 | 46 | 0.410 |
Why?
|
| Crime Victims | 1 | 2014 | 39 | 0.410 |
Why?
|
| Emigrants and Immigrants | 2 | 2026 | 47 | 0.400 |
Why?
|
| Folic Acid | 1 | 2014 | 42 | 0.400 |
Why?
|
| Students | 2 | 2026 | 227 | 0.400 |
Why?
|
| Blood Pressure | 1 | 2016 | 537 | 0.400 |
Why?
|
| Fatty Acids, Essential | 1 | 2013 | 8 | 0.400 |
Why?
|
| Diet Surveys | 5 | 2019 | 43 | 0.400 |
Why?
|
| Pregnancy Complications | 4 | 2026 | 390 | 0.390 |
Why?
|
| Insecticides | 2 | 2012 | 45 | 0.390 |
Why?
|
| Overweight | 2 | 2017 | 254 | 0.390 |
Why?
|
| Iron, Dietary | 1 | 2013 | 9 | 0.390 |
Why?
|
| Hypersensitivity | 1 | 2014 | 73 | 0.390 |
Why?
|
| Minerals | 1 | 2013 | 20 | 0.380 |
Why?
|
| Osteoporotic Fractures | 1 | 2013 | 36 | 0.380 |
Why?
|
| Cat Diseases | 2 | 2003 | 19 | 0.380 |
Why?
|
| Potassium | 1 | 2013 | 98 | 0.370 |
Why?
|
| Social Support | 4 | 2026 | 394 | 0.370 |
Why?
|
| Risk | 6 | 2017 | 375 | 0.360 |
Why?
|
| Dysmenorrhea | 1 | 2012 | 8 | 0.360 |
Why?
|
| Prostaglandins | 1 | 2012 | 18 | 0.360 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2009 | 36 | 0.360 |
Why?
|
| Sleep | 2 | 2025 | 246 | 0.350 |
Why?
|
| Indians, North American | 1 | 2012 | 28 | 0.350 |
Why?
|
| Bone Development | 1 | 2012 | 33 | 0.350 |
Why?
|
| Dog Diseases | 1 | 2012 | 47 | 0.340 |
Why?
|
| Obesity | 6 | 2022 | 1279 | 0.340 |
Why?
|
| Time Factors | 6 | 2025 | 3780 | 0.330 |
Why?
|
| Mammography | 2 | 2010 | 296 | 0.330 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2023 | 28 | 0.330 |
Why?
|
| Vitamin D Deficiency | 3 | 2022 | 42 | 0.330 |
Why?
|
| Anovulation | 2 | 2025 | 10 | 0.330 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2009 | 17 | 0.320 |
Why?
|
| Air Pollutants | 2 | 2022 | 100 | 0.320 |
Why?
|
| Calcifediol | 1 | 2010 | 3 | 0.320 |
Why?
|
| Animals, Domestic | 2 | 2007 | 15 | 0.310 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 201 | 0.310 |
Why?
|
| Male | 24 | 2026 | 31435 | 0.300 |
Why?
|
| Attitude to Health | 1 | 2012 | 296 | 0.300 |
Why?
|
| Interleukin-6 | 4 | 2019 | 324 | 0.300 |
Why?
|
| Asthma | 1 | 2014 | 490 | 0.290 |
Why?
|
| Adaptation, Psychological | 3 | 2026 | 278 | 0.280 |
Why?
|
| Bhutan | 6 | 2026 | 23 | 0.270 |
Why?
|
| Cotinine | 1 | 2007 | 20 | 0.270 |
Why?
|
| Micronutrients | 2 | 2018 | 20 | 0.260 |
Why?
|
| Cause of Death | 2 | 2024 | 221 | 0.260 |
Why?
|
| Child Abuse | 2 | 2022 | 89 | 0.250 |
Why?
|
| Health Behavior | 1 | 2010 | 485 | 0.250 |
Why?
|
| Health Status | 1 | 2009 | 448 | 0.250 |
Why?
|
| Marijuana Abuse | 1 | 2026 | 24 | 0.240 |
Why?
|
| Child Abuse, Sexual | 2 | 2018 | 26 | 0.230 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2005 | 2 | 0.230 |
Why?
|
| Flax | 3 | 2011 | 7 | 0.230 |
Why?
|
| Hydrocortisone | 2 | 2024 | 192 | 0.230 |
Why?
|
| Legislation, Drug | 1 | 2025 | 22 | 0.230 |
Why?
|
| Antioxidants | 1 | 2007 | 252 | 0.230 |
Why?
|
| Alaska | 3 | 2016 | 5 | 0.230 |
Why?
|
| Unemployment | 1 | 2025 | 19 | 0.220 |
Why?
|
| Sick Leave | 1 | 2025 | 24 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 739 | 0.220 |
Why?
|
| Peer Group | 1 | 2026 | 114 | 0.220 |
Why?
|
| Bisexuality | 1 | 2024 | 14 | 0.220 |
Why?
|
| Sweating | 1 | 2024 | 27 | 0.220 |
Why?
|
| Cannabis | 1 | 2025 | 54 | 0.210 |
Why?
|
| Homosexuality, Female | 1 | 2024 | 22 | 0.210 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2327 | 0.210 |
Why?
|
| Receptors, Calcitriol | 3 | 2009 | 33 | 0.200 |
Why?
|
| India | 2 | 2024 | 165 | 0.200 |
Why?
|
| Psychological Tests | 1 | 2024 | 48 | 0.200 |
Why?
|
| Ultraviolet Rays | 2 | 2022 | 153 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2019 | 382 | 0.200 |
Why?
|
| Nails | 1 | 2024 | 39 | 0.200 |
Why?
|
| Breast Diseases | 2 | 2021 | 45 | 0.190 |
Why?
|
| Selenium | 1 | 2023 | 27 | 0.190 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 42 | 0.190 |
Why?
|
| Live Birth | 1 | 2022 | 21 | 0.190 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 12 | 0.190 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2023 | 17 | 0.180 |
Why?
|
| Child, Preschool | 3 | 2024 | 2090 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2024 | 131 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 169 | 0.180 |
Why?
|
| Body Height | 1 | 2022 | 66 | 0.180 |
Why?
|
| Mass Screening | 1 | 2007 | 700 | 0.170 |
Why?
|
| Birth Weight | 1 | 2022 | 83 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2017 | 25 | 0.170 |
Why?
|
| Follicular Atresia | 1 | 2021 | 3 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 365 | 0.170 |
Why?
|
| Confidence Intervals | 4 | 2012 | 237 | 0.170 |
Why?
|
| Depressive Disorder | 2 | 2014 | 284 | 0.170 |
Why?
|
| Registries | 4 | 2026 | 935 | 0.170 |
Why?
|
| Weight Gain | 1 | 2022 | 165 | 0.170 |
Why?
|
| Quality of Life | 2 | 2025 | 1271 | 0.160 |
Why?
|
| Contraception | 1 | 2021 | 72 | 0.160 |
Why?
|
| Racism | 1 | 2022 | 93 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 264 | 0.160 |
Why?
|
| Puberty | 1 | 2021 | 59 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 186 | 0.160 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1570 | 0.160 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 94 | 0.160 |
Why?
|
| Air Pollution | 1 | 2020 | 42 | 0.160 |
Why?
|
| Cytokines | 2 | 2015 | 967 | 0.160 |
Why?
|
| Work Schedule Tolerance | 1 | 2019 | 22 | 0.150 |
Why?
|
| Prognosis | 2 | 2015 | 1793 | 0.150 |
Why?
|
| Dyslipidemias | 1 | 2019 | 39 | 0.140 |
Why?
|
| Pilot Projects | 3 | 2026 | 1030 | 0.140 |
Why?
|
| Suicide, Attempted | 3 | 2022 | 112 | 0.140 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2018 | 4 | 0.140 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 17 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 859 | 0.140 |
Why?
|
| Sexual Behavior | 1 | 2020 | 192 | 0.140 |
Why?
|
| Puerto Rico | 6 | 2017 | 143 | 0.140 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 67 | 0.140 |
Why?
|
| Body Weight | 2 | 2017 | 376 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2011 | 83 | 0.140 |
Why?
|
| Epidemiologic Studies | 1 | 2018 | 34 | 0.140 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2018 | 13 | 0.130 |
Why?
|
| Abdominal Fat | 1 | 2017 | 5 | 0.130 |
Why?
|
| Stearic Acids | 1 | 2017 | 9 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1117 | 0.130 |
Why?
|
| Age of Onset | 1 | 2018 | 175 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2016 | 252 | 0.130 |
Why?
|
| Age Distribution | 2 | 2016 | 262 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 295 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2017 | 47 | 0.130 |
Why?
|
| Interleukin-4 | 2 | 2015 | 147 | 0.130 |
Why?
|
| Interleukin-12 | 2 | 2015 | 127 | 0.130 |
Why?
|
| Infant, Newborn | 6 | 2021 | 1441 | 0.130 |
Why?
|
| Interleukin-2 | 2 | 2015 | 167 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 408 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2019 | 202 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 40 | 0.120 |
Why?
|
| Tea | 1 | 2016 | 32 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2017 | 210 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2022 | 749 | 0.120 |
Why?
|
| Nepal | 3 | 2023 | 95 | 0.120 |
Why?
|
| Insulin | 2 | 2017 | 695 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2015 | 576 | 0.110 |
Why?
|
| Progesterone | 2 | 2014 | 165 | 0.110 |
Why?
|
| Interviews as Topic | 2 | 2020 | 535 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2017 | 502 | 0.110 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 33 | 0.110 |
Why?
|
| Ovulation Detection | 1 | 2014 | 4 | 0.110 |
Why?
|
| Nurse Midwives | 1 | 2014 | 11 | 0.100 |
Why?
|
| Ovulation | 1 | 2014 | 28 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2012 | 806 | 0.100 |
Why?
|
| Comorbidity | 2 | 2025 | 1122 | 0.100 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 44 | 0.100 |
Why?
|
| Luteinizing Hormone | 1 | 2014 | 101 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2017 | 410 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2012 | 606 | 0.100 |
Why?
|
| Reproductive Health | 1 | 2014 | 25 | 0.100 |
Why?
|
| Midwifery | 1 | 2014 | 37 | 0.100 |
Why?
|
| Urban Population | 1 | 2015 | 201 | 0.100 |
Why?
|
| Maternal Exposure | 1 | 2014 | 43 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 30 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 11 | 0.100 |
Why?
|
| Chemokines | 1 | 2014 | 99 | 0.100 |
Why?
|
| Fertility | 2 | 2024 | 85 | 0.100 |
Why?
|
| Cats | 2 | 2003 | 92 | 0.090 |
Why?
|
| Health Promotion | 3 | 2022 | 524 | 0.090 |
Why?
|
| Mastodynia | 1 | 2012 | 3 | 0.090 |
Why?
|
| Mexico | 1 | 2012 | 45 | 0.090 |
Why?
|
| Irritable Mood | 1 | 2012 | 17 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 812 | 0.090 |
Why?
|
| Animals | 5 | 2012 | 21494 | 0.090 |
Why?
|
| Community Mental Health Centers | 1 | 2012 | 16 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 104 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 80 | 0.090 |
Why?
|
| Back Pain | 1 | 2012 | 49 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1378 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 296 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 99 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 54 | 0.090 |
Why?
|
| Nutrition Assessment | 2 | 2010 | 28 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 66 | 0.080 |
Why?
|
| Particulate Matter | 2 | 2022 | 72 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 149 | 0.080 |
Why?
|
| C-Peptide | 1 | 2011 | 24 | 0.080 |
Why?
|
| Riboflavin | 1 | 2011 | 18 | 0.080 |
Why?
|
| Thiamine | 1 | 2011 | 21 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 462 | 0.080 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 199 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 77 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2014 | 889 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2023 | 592 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2014 | 535 | 0.080 |
Why?
|
| Seasonal Affective Disorder | 1 | 2009 | 2 | 0.080 |
Why?
|
| Biogenic Monoamines | 1 | 2009 | 5 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2010 | 90 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 197 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 745 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2010 | 498 | 0.070 |
Why?
|
| Sunlight | 1 | 2009 | 28 | 0.070 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2017 | 37 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1059 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2026 | 5832 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 312 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2025 | 6956 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 302 | 0.070 |
Why?
|
| Energy Intake | 2 | 2024 | 173 | 0.070 |
Why?
|
| Sex Factors | 2 | 2023 | 995 | 0.060 |
Why?
|
| Heart Failure | 1 | 2015 | 968 | 0.060 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 47 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2006 | 25 | 0.060 |
Why?
|
| Prolactin | 1 | 2006 | 40 | 0.060 |
Why?
|
| Biological Specimen Banks | 1 | 2026 | 23 | 0.060 |
Why?
|
| United Kingdom | 1 | 2026 | 86 | 0.060 |
Why?
|
| Lactose | 1 | 2006 | 10 | 0.060 |
Why?
|
| Community-Based Participatory Research | 1 | 2026 | 63 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 2 | 2017 | 59 | 0.060 |
Why?
|
| Diet Records | 1 | 2005 | 35 | 0.060 |
Why?
|
| Siblings | 1 | 2025 | 41 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 187 | 0.050 |
Why?
|
| New Hampshire | 1 | 2024 | 43 | 0.050 |
Why?
|
| Europe | 1 | 2005 | 200 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 2 | 2017 | 24 | 0.050 |
Why?
|
| Meals | 1 | 2024 | 27 | 0.050 |
Why?
|
| Fast Foods | 1 | 2024 | 13 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1663 | 0.050 |
Why?
|
| Hazardous Substances | 1 | 2003 | 16 | 0.050 |
Why?
|
| Food Handling | 1 | 2024 | 60 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2024 | 162 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 290 | 0.050 |
Why?
|
| Testosterone | 1 | 2023 | 128 | 0.050 |
Why?
|
| Benzene | 1 | 2022 | 6 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 33 | 0.050 |
Why?
|
| Estrone | 1 | 2022 | 13 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 127 | 0.040 |
Why?
|
| Reproductive History | 1 | 2022 | 17 | 0.040 |
Why?
|
| Ovarian Reserve | 1 | 2021 | 9 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 770 | 0.040 |
Why?
|
| Pain | 1 | 2024 | 400 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 1672 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2010 | 96 | 0.040 |
Why?
|
| Problem Solving | 1 | 2020 | 32 | 0.040 |
Why?
|
| Parents | 1 | 2024 | 418 | 0.040 |
Why?
|
| Poverty | 2 | 2015 | 307 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 10 | 0.030 |
Why?
|
| Psychological Trauma | 1 | 2018 | 23 | 0.030 |
Why?
|
| Dominican Republic | 1 | 2017 | 23 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 21 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2022 | 492 | 0.030 |
Why?
|
| Educational Status | 2 | 2008 | 279 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 40 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 766 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1720 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 200 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 784 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 11183 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 81 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Yogurt | 1 | 2015 | 5 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Pakistan | 1 | 2015 | 15 | 0.030 |
Why?
|
| Seafood | 1 | 2015 | 14 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 74 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 96 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 136 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 67 | 0.030 |
Why?
|
| Urinalysis | 1 | 2014 | 37 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 103 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 75 | 0.030 |
Why?
|
| New York | 1 | 2014 | 144 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 276 | 0.020 |
Why?
|
| Research | 1 | 2014 | 195 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 384 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 605 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2011 | 26 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 398 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2011 | 62 | 0.020 |
Why?
|
| Hydroxyestrones | 1 | 2010 | 4 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2011 | 173 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 295 | 0.020 |
Why?
|
| Censuses | 1 | 2008 | 18 | 0.020 |
Why?
|
| Maternal Age | 1 | 2008 | 35 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 44 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 484 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 162 | 0.020 |
Why?
|
| Employment | 1 | 2008 | 132 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 178 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 213 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 677 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 527 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 5684 | 0.010 |
Why?
|